Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KMM Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of high-quality generic injectable products. Headquartered in Boca Raton, Florida, the company targets niche markets within the hospital and institutional sectors, specifically in the areas of anesthesiology and pain management. Their commercial portfolio includes essential medications such as Ketorolac Tromethamine, Glycopyrrolate, and Neostigmine Methylsulfate. KMM Pharmaceuticals prides itself on maintaining a robust supply chain to provide affordable and reliable therapeutic options for critical care. The company is led by an experienced management team with a proven track record in the generic pharmaceutical industry. By focusing on complex formulations and essential medicines, KMM addresses critical market needs and drug shortages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KMM Pharmaceuticals.